Imunon, Inc. Effective Tax Rate
Imunon, Inc. (IMNN) reported Effective Tax Rate of 6.10% for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2025-02-27
- Imunon, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 6.10%, a 48.78% increase from fiscal 2022.
- Imunon, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 4.10%, a 33.87% decline from fiscal 2021.
- Imunon, Inc. effective income tax rate reconciliation, percent for fiscal 2021 was 6.20%, a 22.50% decline from fiscal 2020.
- Imunon, Inc. effective income tax rate reconciliation, percent for fiscal 2020 was 8.00%, a 17.53% decline from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2023-12-31 | 6.10% 10-K · filed 2025-02-27 | |
| 2022-12-31 | 4.10% 10-K · filed 2024-03-28 | 4.60% 10-K · filed 2023-03-30 |
| 2021-12-31 | 6.20% 10-K · filed 2023-03-30 | |
| 2020-12-31 | 8.00% 10-K · filed 2022-03-31 | |
| 2019-12-31 | 9.70% 10-K · filed 2021-03-19 | |
| 2018-12-31 | 46.70% 10-K · filed 2020-03-25 | |
| 2017-12-31 | 0.00% 10-K · filed 2019-03-29 | |
| 2015-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-30 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-12 | |
| 2011-12-31 | 0.00% 10-K · filed 2014-03-13 | |
| 2010-12-31 | 0.00% 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |